Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Traditional Chinese herbs and natural products in hyperuricemia-induced chronic kidney disease
Letian Yang, Bo Wang, Liang Ma, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Kidney fibrosis: from mechanisms to therapeutic medicines
Rongshuang Huang, Ping Fu, Liang Ma
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 255
Piperine Improves Hyperuricemic Nephropathy by Inhibiting URAT1/GLUT9 and the AKT-mTOR Pathway
Lu Li, Kunlu Zhao, Jian Luo, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 12, pp. 6565-6574
Closed Access | Times Cited: 10
Fuling-Zexie formula attenuates hyperuricemia-induced nephropathy and inhibits JAK2/STAT3 signaling and NLRP3 inflammasome activation in mice
Meixi Lu, Jiyuan Yin, Tianshu Xu, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117262-117262
Closed Access | Times Cited: 17
Gut microecology: effective targets for natural products to modulate uric acid metabolism
Hui Wang, Yixuan Zheng, Mengfan Yang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Paeonia × suffruticosa Andrews leaf extract and its main component apigenin 7-O-glucoside ameliorate hyperuricemia by inhibiting xanthine oxidase activity and regulating renal urate transporters
Yan Zhang, Li Yao, Chang Li, et al.
Phytomedicine (2023) Vol. 118, pp. 154957-154957
Closed Access | Times Cited: 14
Osthole ameliorates early diabetic kidney damage by suppressing oxidative stress, inflammation and inhibiting TGF-β1/Smads signaling pathway
Qiangsheng Li, Yifei Wang, Yan Jia, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112131-112131
Closed Access | Times Cited: 5
Herb-Drug Interactions
James Oluwagbamigbe Fajemiroye, Ânderson Luiz-Ferreira, Roberto Saavedra-Rodríguez
(2025), pp. 87-110
Closed Access
Inonotus obliquus (chaga) ameliorates folic acid-induced renal fibrosis in mice: the crosstalk analysis among PT cells, macrophages and T cells based on single-cell sequencing
Yue-Ling Peng, Yaling Zhang, Rui Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Overview of pharmacodynamical research of traditional Chinese medicine on hyperuricemic nephropathy: from the perspective of dual-regulatory effect on the intestines and kidneys
Ting Wang, Li Li, Liu Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Ethanol extract of Sophora japonica flower bud, an effective potential dietary supplement for the treatment of hyperuricemia
Danni Song, Honghui Zhao, Lingling Wang, et al.
Food Bioscience (2023) Vol. 52, pp. 102457-102457
Closed Access | Times Cited: 12
Bioactive Evaluation of Naringenin in Ameliorating Hyperuricemia‐Induced Liver Injury by Inhibiting Xanthine Oxidase
Xiaoyue Zhang, Linfeng Liu, Zhaosen Fan, et al.
eFood (2025) Vol. 6, Iss. 1
Open Access
Role of gasdermins in chronic kidney disease
Hanchao Gao, Ting Xie, Yunyi Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Research progress of treating hyperuricemia in rats and mice with traditional Chinese medicine
Haodong Bai, Zidong Zhang, Mingtao Zhu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Cyclocarya paliurus leaves alleviate hyperuricemic nephropathy via modulation of purine metabolism, antiinflammation, and antifibrosis
Rui Gui, Yikun Wang, Jianping Wu, et al.
Journal of Functional Foods (2023) Vol. 103, pp. 105485-105485
Open Access | Times Cited: 4
Design, synthesis and evaluation of a myricetin and nobiletin hybrid compound for alleviating hyperuricemia based on metabolomics and gut microbiota
Yan Li, Liu‐Yang Pu, Yayun Li, et al.
RSC Advances (2023) Vol. 13, Iss. 31, pp. 21448-21458
Open Access | Times Cited: 4
Possible correlated signaling pathways with chronic urate nephropathy: A review
Kaiqing Li, Yanchun Ma, Xue Xia, et al.
Medicine (2023) Vol. 102, Iss. 32, pp. e34540-e34540
Open Access | Times Cited: 4
Establishment and evaluation of a nomogram prediction model for the risk of vascular calcification in stage 5 chronic kidney disease patients
Yan Yang, Wenxue Liang, Wenyu Gong, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Hyperuricemia: Current State and Prospects
Wei‐Zheng Zhang
(2024)
Open Access | Times Cited: 1
Ameliorative action of “daitongxiao” against hyperuricemia includes the “uric acid transporter group”
Lijie Zheng, Yuanmei Bai, Yan Wan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Advances in the study of key cells and signaling pathways in renal fibrosis and the interventional role of Chinese medicines
Lijuan Liang, Youjun Mi, Shihan Zhou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Recent Advances in Synthetic Drugs and Natural Actives Interacting with OAT3
Ying Chen, Hongyan Li, Ke Wang, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4740-4740
Open Access | Times Cited: 3
Dispelling Dampness, Relieving Turbidity and Dredging Collaterals Decoction, Attenuates Potassium Oxonate-Induced Hyperuricemia in Rat Models
Haibo Liu, Min Yang, Li Wan, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 2287-2301
Open Access | Times Cited: 2
Evaluating the therapeutic effects of NiaoDuQing particles on chronic kidney disease based on real world study
Rui Sun, Jianfeng Hao, Qian Li, et al.
Technology and Health Care (2024), pp. 1-9
Closed Access
Efficacy and safety of Liqingtong granules in the treatment of hyperuricemia: A randomized double-blind placebo-controlled pilot clinical trial
Jinlian Liu, Yi Yang, Meiyu Lv, et al.
Journal of Traditional Chinese Medical Sciences (2024)
Open Access
Integrating metabolomics with network pharmacology to reveal the mechanism of Poria cocos in hyperuricemia treatment
Yiru Wang, Zhijie Yu, Zihao Zhang, et al.
Journal of Ethnopharmacology (2024), pp. 118977-118977
Closed Access
Page 1 - Next Page

Scroll to top